Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001424

Director sold 3,934 shares at an average $38.07 ($149,759)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Waddill William D. Director 2024-01-11 Sale 10b5-1 −2,634 $37.81 $99,592 49,170 D
Waddill William D. Director 2024-01-11 Sale 10b5-1 −1,300 $38.59 $50,167 47,870 D
Open-market sales · 3,934 sh · avg $38.07 · $149,759
Loading xslF345X05/wk-form4_1705446389.xml…